Weight loss drugs are likely to stay in demand for a long time judging by the obesity trend as shown by latest CDC data ...

Eli Lilly said it will spend $1.8 billion to boost production in Ireland of its popular diabetes and weight-loss drugs, along with ingredients for its recently approved Alzheimer’s treatment, Kisunla.

As weight-loss treatments dominate the pharmaceutical market, Swiss drugmaker Novartis AG (SWX: NOVN) is choosing a different ...

Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and a newly approved treatment for Alzheimer's, the drugmaker said ...

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal ...

Chinese pharmaceutical and biotech companies are leading development of glucagon-like peptide-1 receptor agonists as Novo Nordisk A/S and Eli Lilly and Co. edge closer to launching blockbuster ...

Weight loss medications have been a game-changer in treating people with obesity, but their high price tag has put them out of reach for many Americans. Now, Eli Lilly is looking to lower that ...

It was a dose-ranging study, and the range of weight loss seen with Lilly’s drug was 9.4% to 14.7% at 36 weeks, compared to 2.3% with placebo. The company is now running phase 3 trials of the ...

DeepWell Digital Therapeutics received 510 (k) clearance from the FDA on its biofeedback software development kit for use in ...

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above ...